Table 2.

Differences in the QLQ-SH22 scales by treatment

	On active treatment			Off treatment
	M ± SD	Median	N	M ± SD	Median	N	P	Cohen’s d
Sexual satisfactiona	37.44 ± 25.18	32.5	85	46.66 ± 26.84	47.30	241	.021*	.36
Importance of sexual activitya	48.72 ± 34.89	49.06	91	51.25 ± 31.34	51.67	247	.563
Libidoa	37.93 ± 39.43	30.24	87	55.05 ± 33.90	57.07	244	< .001*	.60
Treatment effect on sexual activitya	34.49 ± 37.72	26.66	86	53.30 ± 37.38	54.70	237	< .001*	.50
Communication with professionalsa	15.75 ± 28.69	10.97	91	16.45 ± 28.06	12.03	237	.840
Security with partnera	67.84 ± 35.05	73.88	85	69.60 ± 34.65	75.90	227	.632
Confidence erectiona	38.09 ± 33.80	33.33	21	42.85 ± 36.61	33.33	77	.593
Masculinitya	53.96 ± 42.79	66.6	21	64.10 ± 41.44	66.6	78	.285
Femininitya	60.38 ± 37.17	63.54	69	68.32 ± 35.51	75.14	161	.127
Sexual painb	19.15 ± 27.88	8.64	85	18.20 ± 24.64	9.15	239	.769
Worry incontinenceb	14.01 ± 27.08	9.83	88	18.85 ± 30.38	13.49	244	.189
Fatigueb	53.81 ± 40.60	57.29	83	35.45 ± 33.54	30.70	236	< .001*	.50
Vaginal drynessb	46.32 ± 38.16	45.24	59	42.93 ± 37.58	38.981	125	.570

^*significant value p < 0.05, according to T-Test

^ahigh values indicate high functioning/low symptoms

^bhigh values indicate low functioning/high symptoms